Welcome
Support Centre
05 July 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
The effectiveness and cost effectiveness of screening and stepped-care intervention for alcohol use disorders in the primary care setting
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN55274820
Date ISRCTN assigned04/12/2006
Local reference number(s)N/A
Public titleThe effectiveness and cost effectiveness of screening and stepped-care intervention for alcohol use disorders in the primary care setting
Scientific title
AcronymSTEPWICE
Disease/condition/study domainAlcohol Use Disorders
Study hypothesis1. Screening and stepped care interventions for alcohol use disorder are as effective as minimal interventions in primary care.
2. Screening and stepped care interventions for alcohol use disorder are as cost-effective as minimal interventions in primary care.
Design/methodologyRandomised controlled trial
Research ethics reviewIechyd Morgannwg Health Local Research Ethics Committee approval gained on 5th July 2000.
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Male
2. Age 18 to 65 (the reason for limiting the age range is that patients above and below this range are catered for by different services in Step 3)
3. Alcohol Use Disorders Identification Test (AUDIT) score more than or equal to eight
4. Diagnosis of an Alcohol Use Disorder according to the Internation Classification of Diseases (ICD-10) (hazardous or harmful drinking, alcohol dependence) as assessed by the baseline research interview
5. Consent to participate in either treatment, and follow-up
6. Willing to nominate an independent informant who the research team can contact to obtain information at baseline and during follow-up, and to nominate a ¿locator¿ who will be able to assist in tracing the subject at follow-up (the independent informant and locator may be the same person)
7. Stable place of residence
8. Living within commuting distance of the practice
9. No treatment for substance misuse in previous 30 days
Participants - exclusion criteria1. Current severe mental illness
2. Primary drug dependence (except nicotine and cannabis)
3. Severe physical illness that would preclude participation
4. Current legal problems likely to interfere with follow-up
5. Severe brain damage or mental impairment
Patient information material
Anticipated start date01/06/2000
Anticipated end date31/05/2003
Status of trialCompleted
Target number of participants236
InterventionsStepped Care Intervention (SCI):
This consists of three care steps:
a. All SCI subjects receive one 40-minute session of Brief Motivational Intervention (BMI) in the general practice setting conducted by a trained Practice Nurse (PN). This intervention will be manual-guided using the method of Rollnick et al. All SCI subjects will then be followed-up by the PN with a phone call at two weeks, and face-to-face interview at one month post intervention in the primary care setting to assess response to the intervention. Subjects ¿not improved¿ will be referred to Step b.
b. Manual-guided, outpatient Motivational Enhancement Therapy (MET) (four one hour sessions over two weeks) adapted from the Medical Research Council (MRC) funded UK Alcohol Treatment Trial intervention protocol (similar to the MET intervention used in Project MATCH), conducted by a trained Addiction Prevention Practitioner (APP) attached to the collaborating practices. The APP model has been described by Ghodse et al. This will be followed by a further phone call at two weeks and a follow-up face-to-face interview at one month post-MET by the PN to assess response to intervention.
c. Subjects ¿not improved¿ will be referred to a specialist Community Alcohol Team (CAT) to receive specialist treatment (including, as necessary, inpatient care, outpatient counselling, group therapy, relapse prevention treatment, medication) with no limit on duration or intensity of Intervention.

Control intervention:
Minimal intervention will consist of one five minute session of advice to cut down drinking conducted by the trained PN and provision of an information leaflet on services available locally for problem drinkers, and a self-help booklet. The minimal intervention will also be manual guided.
Primary outcome measure(s)Alcohol consumption obtained using the Time Line Follow-Back interview method (TLFB). This method will be used to provide two measures identical to the primary outcome measures used in project MATCH (Project MATCH Research Group, 1997), namely:
1. Mean number of Drinks per Drinking Day (DDD)
2. Percentage of Days Abstinent (PDA)
Secondary outcome measure(s)1. Alcohol-related problems: Alcohol Problems Questionnaire (APQ)
2. Blood investigations (Gamma-GlutamylTransferase [GGT], Carbohydrate-Deficient Transferrin [CDT-Axis], Mean Corpuscular Volume [MCV])
3. Health related Quality of Life (Euroqol questionnaire [EQ-5D], Short Form health surveys [SF-36, SF-12])
4. Health economic measures
5. Patient compliance (using attendance records)
6. Patient and clinician satisfaction using scales developed by the Kings College Group.

Alcohol consumption and secondary measures 1, 2, & 3 will be included in the baseline assessment to:
a. test the adequacy of matching between groups, and
b. to act as covariates in subsequent analyses to control for baseline values.

The Severity of Alcohol Dependence Questionnaire (SADQ), the Situational Confidence Questionnaire (SCQ) and the short Readiness to Change Questionnaire will also be administered at baseline and later investigated as predictors of outcome and care step utilisation.
Sources of fundingWales Office of Research and Development (UK)
Sponsor nameWales Office of Research and Development (UK)
Sponsor detailsNational Assembly for Wales
Cardiff Bay
Cardiff
United Kingdom
CF99 1NA
Sponsor telephone+44 (0)29 2082 5111
Sponsor emailWORD.Wales@gsi.gov.uk
Sponsor websitehttp://www.word.wales.gov.uk/
Contact nameProf Colin Drummond
Contact detailsSection of Addictive Behaviour
St Georges University of London
Cranmer Terrace
London
United Kingdom
SW17 0RE
Contact emailsgju970@sgul.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN55274820
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central